Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Cholangiocarcinoma
Impact of Liver-Directed Radiation Therapy in Patients with Metastatic iCCA
Read More
Cholangiocarcinoma
Addition of Toripalimab to Standard Chemotherapy Gemcitabine plus S-1 for the First-Line Treatment of Advanced BTCs
Read More
Cholangiocarcinoma
Results from the STAMP Study: Adjuvant GemCis versus Capecitabine in Patients with Resected Lymph Node–Positive eCCA
Read More
Cholangiocarcinoma
Assessment of QOL in BTC Clinical Trials: A Systematic Review
Read More
Cholangiocarcinoma
Immune-Related AEs in the TOPAZ-1 Study of Durvalumab plus GemCis in Advanced BTC
Read More
Cholangiocarcinoma
2022 Year in Review: Cholangiocarcinoma
Read More
Cholangiocarcinoma
Results from the ABC-06 Trial: Tumor Markers in Advanced BTCs Treated with Second-Line Active Symptom Control Alone or in Combination with FOLFOX
Read More
Cholangiocarcinoma
Interim Analysis of the FIDES-01 Study
Read More
Cholangiocarcinoma
PROs from the TOPAZ-1 Study Evaluating Durvalumab plus GemCis in Advanced BTCs
Read More
Cholangiocarcinoma
Results from the Regional Subgroup Analysis of the TOPAZ-1 Study Evaluating Durvalumab plus GemCis in Advanced BTCs
Read More
1
2
3
Page 2 of 3
Results 11 - 20 of 29